These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11792308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients.
    Mathur VS.
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S35-40. PubMed ID: 12556736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N, Malcangi V, Dalfino L, Trerotoli P, Guagliardi C, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T.
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [Abstract] [Full Text] [Related]

  • 8. Initial experience with fenoldopam in children.
    Strauser LM, Pruitt RD, Tobias JD.
    Am J Ther; 1999 Sep; 6(5):283-8. PubMed ID: 11329109
    [Abstract] [Full Text] [Related]

  • 9. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I, Germi MR, Beatini M, Fontana S, Bertocchi M, Porcile E, Saltalamacchia L, Ornis S, Ghinolfi D, Bonifazio L, Valente U.
    Transplant Proc; 2005 Sep; 37(6):2474-5. PubMed ID: 16182714
    [Abstract] [Full Text] [Related]

  • 10. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
    Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD.
    Am J Kidney Dis; 2005 Jul; 46(1):26-34. PubMed ID: 15983954
    [Abstract] [Full Text] [Related]

  • 11. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.
    Murphy MB, Murray C, Shorten GD.
    N Engl J Med; 2001 Nov 22; 345(21):1548-57. PubMed ID: 11794223
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A, Epstein DL, Epstein M.
    J Clin Pharmacol; 2004 Dec 22; 44(12):1342-51. PubMed ID: 15545304
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiocontrast-induced acute renal failure: allocations and outcomes.
    Mehran R, Ashby DT.
    Rev Cardiovasc Med; 2001 Dec 22; 2 Suppl 1():S9-13. PubMed ID: 12439362
    [Abstract] [Full Text] [Related]

  • 17. Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies.
    Post JB, Frishman WH.
    J Clin Pharmacol; 1998 Jan 22; 38(1):2-13. PubMed ID: 9597553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preventing contrast-induced nephropathy with fenoldopam.
    Hunter DW, Chamsuddin A, Bjarnason H, Kowalik K.
    Tech Vasc Interv Radiol; 2001 Mar 22; 4(1):53-6. PubMed ID: 11981789
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.